Skip to main content
. 2020 Aug 10;5(33):20746–20754. doi: 10.1021/acsomega.0c00442

Figure 5.

Figure 5

(A) Active AMP prediction using CAMPR3. (B) Peptide series 1 and 2 tested against E. coli, A. baumannii, and S. aureus. Peptide concentrations were 0, 0.64, 3.2, 16, 80, and 400 μg/mL. Row labels are interpolation step for each peptide series. The absence or inhibition of colony formation is indicative of AMP activity.